Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance
- 9 November 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (10), 1673-1683
- https://doi.org/10.1016/0006-2952(95)02069-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemiaLeukemia Research, 1994
- Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemiaLeukemia Research, 1994
- Idarubicin is active on MDR cells: evaluation of DNA synthesis inhibition on P388 cell linesAnnals of Hematology, 1993
- A novel 95 kilodalton membrane polypeptide associated with lung cancer drug resistanceLung Cancer, 1993
- A Comparative Analysis of the Sensitivity of Multidrug Resistant (MDR) and Non-MDR Cells to Different Anthracycline DerivativesLeukemia & Lymphoma, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: Chemosensitization by verapamil in relation to P-glycoprotein expressionAnnals of Hematology, 1992
- Multidrug Resistance in Acute Myeloid LeukemiaJNCI Journal of the National Cancer Institute, 1991
- Multidrug Resistance in CancerScientific American, 1989
- LAGRAN program for area and moments in pharmacokinetic analysisComputer Programs in Biomedicine, 1983